Fang, S., Niu, Y., Zhang, W., Zhang, Y., Yu, L., Zhang, Y., & Li, X
These medications mimic a natural hormone in the body that regulates blood sugar levels and appetite
doi: 10.1097/MD.0000000000021950 17
Until recently they have had little support from the two dominant GLP-1 drug makers, Novo Nordisk and Eli Lilly who have not considered addition a high prioroty (Sheridan)
Research Summary by Peptide Key Research Findings by Peptide GHK-CU Research Highlights: Affects expression of over 4,000 genes 36% reduction in fine lines in clinical studies 40-60% faster wound healing vs controls Stimulates collagen I, III, and elastin production Anti-inflammatory and antioxidant effects confirmed AHK-CU Research Highlights: Activates Wnt/-catenin signaling pathway Promotes anagen (growth) phase in hair cycle May reduce DHT through 5-alpha reductase inhibition Improves follicular blood flow SRCP Research Highlights: Enhanced penetration vs first-generation Better stability in formulations Strong wound healing effects Effective scar remodeling For those prioritizing evidence-based choices, GHK-CU has the strongest research foundation
doi: 10.1056/NEJMoa2206038 201 ArmstrongMJGauntPAithalGPBartonDHullDParkerRet al
